Alexandra Strohle

Alexandra Strohle, as Vice President of Portfolio Management and Managing Director of CCG/RSD Europe at Thermo Fisher Scientific, plays a pivotal role in shaping the company's strategic direction across the European region. With over two decades of expertise in procurement, strategic sourcing, category management, and operational excellence, Alexandra has been instrumental in driving innovation and efficiency within highly competitive pharmaceutical and life sciences markets. Her current role involves leading a diverse team of Portfolio Management professionals, sourcing managers, and cross-functional experts responsible for a broad portfolio that includes laboratory equipment and services, life sciences, chemicals, lab consumables, and safety/PPE.

Under Alexandra’s leadership, the European Portfolio Management organization is focused on optimizing product lifecycle management, enhancing supply chain resilience, and accelerating digitalization initiatives to improve process effectiveness and reduce time-to-market. Her strategic approach emphasizes leveraging data-driven insights and lean management principles to streamline procurement processes, negotiate high-impact contracts, and develop innovative product solutions that meet evolving customer needs. Alexandra’s expertise in product management, logistics, and business development ensures that the portfolio aligns with Thermo Fisher’s mission to serve science and advance scientific discovery.

As a member of the European Leadership Team, Alexandra actively contributes to shaping the company’s regional growth strategies, fostering cross-functional collaboration, and driving operational excellence. Her proven ability to deliver on strategic objectives in a VUCA environment underscores her capacity to navigate complex market dynamics while maintaining a focus on customer-centric solutions and sustainable growth. Through her leadership, Thermo Fisher Scientific continues to strengthen its position as the global leader in serving science, supporting innovation in research, diagnostics, and biopharmaceutical development across Europe.